Desmopressin and bleeding risk after percutaneous kidney biopsy

BACKGROUND: Desmopressin is used to reduce bleeding after kidney biopsy but evidence supporting its use is weak, especially in patients with elevated creatinine. The present study was undertaken to evaluate efficacy of desmopressin in reducing bleeding after percutaneous kidney biopsy. METHODS: Retr...

Descripción completa

Detalles Bibliográficos
Autores principales: Athavale, Ambarish, Kulkarni, Hemant, Arslan, Cagil D., Hart, Peter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6858772/
https://www.ncbi.nlm.nih.gov/pubmed/31730448
http://dx.doi.org/10.1186/s12882-019-1595-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6858772/
https://www.ncbi.nlm.nih.gov/pubmed/31730448
http://dx.doi.org/10.1186/s12882-019-1595-4

Ejemplares similares